{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Arbidol", "COVID-19", "Drug-likeness", "Favipiravir", "Hydroxychloroquine", "Phytochemicals", "Remedesivir", "SARS-CoV-2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35617830", "DateCompleted": {"Year": "2023", "Month": "10", "Day": "23"}, "DateRevised": {"Year": "2023", "Month": "10", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "13"}], "Language": ["eng"], "ELocationID": ["10.1016/j.jiph.2022.05.002", "S1876-0341(22)00122-8"], "Journal": {"ISSN": "1876-035X", "JournalIssue": {"Volume": "15", "Issue": "6", "PubDate": {"Year": "2022", "Month": "Jun"}}, "Title": "Journal of infection and public health", "ISOAbbreviation": "J Infect Public Health"}, "ArticleTitle": "Multi-target potential of Indian phytochemicals against SARS-CoV-2: A docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529.", "Pagination": {"StartPage": "662", "EndPage": "669", "MedlinePgn": "662-669"}, "Abstract": {"AbstractText": ["SARS-CoV-2, an emerged strain of corona virus family became almost serious health concern worldwide. Despite vaccines availability, reports suggest the occurrence of SARS-CoV-2 infection even in a vaccinated population. With frequent evolution and expected multiple COVID-19 waves, improved preventive, diagnostic, and treatment measures are required. In recent times, phytochemicals have gained attention due to their therapeutic characteristics and are suggested as alternative and complementary treatments for infectious diseases. This present study aimed to identify potential inhibitors against reported protein targets of SARS-CoV-2.", "We computationally investigated potential SARS-CoV-2 protein targets from the literature and collected druggable phytochemicals from Indian Medicinal Plants, Phytochemistry and Therapeutics (IMPPAT) database. Further, we implemented a systematic workflow of molecular docking, dynamic simulations and generalized born surface area free-energy calculations (MM-GBSA).", "Extensive literature search and assessment of 1508 articles identifies 13 potential SARS-CoV-2 protein targets. We screened 501 druggable phytochemicals with proven biological activities. Analysis of 6513(501\u00a0*13) docked phytochemicals complex, 26 were efficient against SARS-CoV-2. Amongst, 4,8-dihydroxysesamin and arboreal from Gmelina arborea were ranked potential against most of the targets with binding energy ranging between -\u00a010.7 to -\u00a08.2\u00a0kcal/mol. Additionally, comparative docking with known drugs such as arbidol (-6.6 to -5.1\u00a0kcal/mol), favipiravir (-5.5 to -4.5\u00a0kcal/mol), hydroxychloroquine (-6.5 to -5.1\u00a0kcal/mol), and remedesivir (-8.0 to -5.3\u00a0kcal/mol) revealed equal/less affinity than 4,8-dihydroxysesamin and arboreal. Interestingly, the nucleocapsid target was found commonly inhibited by 4,8-dihydroxysesamin and arboreal. Molecular dynamic simulation and Molecular mechanics generalized born surface area (MM-GBSA)calculations reflect that both the compounds possess high inhibiting potential against SARS-CoV-2 including the recently emerged Omicron variant (B.1.1.529).", "Overall our study imparts the usage of phytochemicals as antiviral agents for SARS-CoV-2 infection. Additional in vitro and in vivo testing of these phytochemicals is required to confirm their potency."], "CopyrightInformation": "Copyright \u00a9 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnology, Chettinad Hospital & Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam 603103, India. Electronic address: jencyroshni@gmail.com."}], "LastName": "Roshni", "ForeName": "Jency", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnology, Chettinad Hospital & Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam 603103, India. Electronic address: vaishalir967@gmail.com."}], "LastName": "Vaishali", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnology, Chettinad Hospital & Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam 603103, India. Electronic address: ganeshkumar1742001@gmail.com."}], "LastName": "Ganesh", "ForeName": "K S", "Initials": "KS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biotechnology, Chettinad Hospital & Research Institute (CHRI), Chettinad Academy of Research and Education (CARE), Kelambakkam 603103, India. Electronic address: lakshmi.dharani007@gmail.com."}], "LastName": "Dharani", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia. Electronic address: h.banjer@tu.edu.sa."}], "LastName": "Alzahrani", "ForeName": "Khalid J", "Initials": "KJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia. Electronic address: ak.jamaan@tu.edu.sa."}], "LastName": "Banjer", "ForeName": "Hamsa Jameel", "Initials": "HJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, Albaha University, Albaha 7738-65799, Saudi Arabia. Electronic address: aayfan@bu.edu.sa."}], "LastName": "Alghamdi", "ForeName": "Ali H", "Initials": "AH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Medicine, Al-Faisal University, P.O. Box 50927, Riyadh, 11533, Saudi Arabia; Department of Laboratory Medicine, Security Forces Hospital, Mecca, Saudi Arabia. Electronic address: aalshehri@sfhm.med.sa."}], "LastName": "Theyab", "ForeName": "Abdulrahman", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Multi-omics and Drug Discovery Lab, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute (CHRI), Chettinad Academy of Research and Education(CARE), Kelambakkam 603103, India. Electronic address: shiekssjahmed@gmail.com."}], "LastName": "Ahmed", "ForeName": "Shiek Ssj", "Initials": "SS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Maxillofacial Surgery and Diagnostic Sciences, Division of Oral Pathology, College of Dentistry, Jazan University, Jazan 45412, Saudi Arabia. Electronic address: dr.ravipatil@gmail.com."}], "LastName": "Patil", "ForeName": "Shankargouda", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Infect Public Health", "NlmUniqueID": "101487384", "ISSNLinking": "1876-0341"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "SupplMeshList": ["SARS-CoV-2 variants"], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antiviral Agents"}], "CoiStatement": "Conflict of Interest This study was not funded by any private or government organization. Authors from the four institutes declare that they have no competing interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Renu K., Prasanna P.L., Valsala Gopalakrishnan A. Coronaviruses pathogenesis, comorbidities and multi-organ damage - a review. Life Sci. 2020;255 https://doi:10.1016/j.lfs.2020.117839.", "ArticleIdList": ["PMC7243768", "32450165"]}, {"Citation": "Mokhtari T., Hassani F., Ghaffari N., Ebrahimi B., Yarahmadi A., Hassanzadeh G. COVID-19 and multiorgan failure: a narrative review on potential mechanisms. J Mol Histol. 2020;51(6):613\u2013628. https://doi:10.1007/s10735-020-09915-3.", "ArticleIdList": ["PMC7533045", "33011887"]}, {"Citation": "\u015eenay \u015e. Coronavirus pandemic and cardiovascular issues. Turk GogusKalpDamarCerrahisiDerg. 2020;28(2):227\u2013228. Published 2020 Apr 22. https://doi:10.5606/tgkdc.dergisi.2020.09298.", "ArticleIdList": ["PMC7298384", "32551149"]}, {"Citation": "V'kovski P., Kratzel A., Steiner S., Stalder H., Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19(3):155\u2013170. https://doi:10.1038/s41579-020-00468-6.", "ArticleIdList": ["PMC7592455", "33116300"]}, {"Citation": "Gordon D.E., Jang G.M., Bouhaddou M., et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459\u2013468. https://doi:10.1038/s41586-020-2286-9.", "ArticleIdList": ["PMC7431030", "32353859"]}, {"Citation": "Yadav R., Chaudhary J.K., Jain N., et al. Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells. 2021;10(4):821. https://doi:10.3390/cells10040821.", "ArticleIdList": ["PMC8067447", "33917481"]}, {"Citation": "Gu H., Krishnan P., Ng D.Y.M., et al. Probable transmission of SARS-CoV-2 omicron variant in quarantine hotel, Hong Kong, China, November 2021. Emerg Infect Dis. 2022;28(2):460\u2013462. https://doi:10.3201/eid2802.212422.", "ArticleIdList": ["PMC8798678", "34860154"]}, {"Citation": "Singh T.U., Parida S., Lingaraju M.C., Kesavan M., Kumar D., Singh R.K. Drug repurposing approach to fight COVID-19. Pharm Rep. 2020;72(6):1479\u20131508. https://doi:10.1007/s43440-020-00155-6.", "ArticleIdList": ["PMC7474498", "32889701"]}, {"Citation": "Jie X., Hongmei Y., Ping F., Kuikui Z., Bohan Y., Rui M. Beneficial effect of Arbidol in the management of COVID-19 infection. Aging (Albany NY) 2021;13(7):9253\u20139264. https://doi:10.18632/aging.202867.", "ArticleIdList": ["PMC8064174", "33811756"]}, {"Citation": "Manabe T., Kambayashi D., Akatsu H., Kudo K. Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):489. Published 2021 May 27. https://doi:10.1186/s12879\u2013021-06164-x.", "ArticleIdList": ["PMC8159019", "34044777"]}, {"Citation": "Kumar R., Sharma A., Srivastava J.K., Siddiqui M.H., Uddin M.S., Aleya L. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications. Environ SciPollut Res Int. 2021;28(30):40431\u201340444. https://doi:10.1007/s11356-020-12200-1.", "ArticleIdList": ["PMC7808930", "33447984"]}, {"Citation": "Beigel J.H., Tomashek K.M., Dodd L.E., et al. Remdesivir for the treatment of covid-19 - final report. N Engl J Med. 2020;383(19):1813\u20131826. https://doi:10.1056/NEJMoa2007764.", "ArticleIdList": ["PMC7262788", "32445440"]}, {"Citation": "Nojomi M., Yassin Z., Keyvani H., et al. Effect of arbidol (Umifenovir) on COVID-19: a randomized controlled trial. BMC Infect Dis. 2020;20(1):954. https://doi:10.1186/s12879-020-05698-w.", "ArticleIdList": ["PMC7734453", "33317461"]}, {"Citation": "Kaur R.J., Charan J., Dutta S., et al. Favipiravir use in COVID-19: analysis of suspected adverse drug events reported in the WHO database. Infect Drug Resist. 2020;13:4427\u20134438. https://doi:10.2147/IDR.S287934.", "ArticleIdList": ["PMC7751706", "33364790"]}, {"Citation": "Gevers S., Kwa M.S.G., Wijnans E., van Nieuwkoop C. Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Clin Microbiol Infect. 2020;26(9):1276\u20131277. https://doi:10.1016/j.cmi.2020.05.006.", "ArticleIdList": ["PMC7228887", "32422406"]}, {"Citation": "Gupta A.K., Parker B.M., Priyadarshi V., Parker J. Cardiac adverse events with Remdesivir in COVID-19 Infection. Cureus. 2020;12(10) https://doi:10.7759/cureus.11132.", "ArticleIdList": ["PMC7682945", "33240723"]}, {"Citation": "Ahmad S., Zahiruddin S., Parveen B., et al. Indian medicinal plants and formulations and their potential against COVID-19-preclinical and clinical research. Front Pharm. 2021;11 https://doi:10.3389/fphar.2020.578970.", "ArticleIdList": ["PMC7962606", "33737875"]}, {"Citation": "Rasool N., Bakht A., Hussain W. Analysis of inhibitor binding combined with reactivity studies to discover the potentially inhibiting phytochemicals targeting chikungunya viral replication. Curr Drug Disco Technol. 2021;18(3):437\u2013450. https://doi:10.2174/1570163817666200312102659.", "ArticleIdList": ["32164512"]}, {"Citation": "Kwofie S.K., Broni E., Teye J., et al. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24. Comput Biol Med. 2019;113 https://doi:10.1016/j.compbiomed.2019.103414.", "ArticleIdList": ["31536833"]}, {"Citation": "Byler K.G., Ogungbe I.V., Setzer W.N. In-silico screening for anti-Zika virus phytochemicals. J Mol Graph Model. 2016;69:78\u201391. https://doi:10.1016/j.jmgm.2016.08.011.", "ArticleIdList": ["PMC7185537", "27588363"]}, {"Citation": "Aarogyam UK.A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19, Available from: https://clinicaltrials.gov/ct2/show/NCT04621903 (Accessed on November 29, 2021a)."}, {"Citation": "Adel Gomaa. Complementary Intervention for COVID-19, Available from: https://clinicaltrials.gov/ct2/show/NCT04487964 (Accesses on November 29, 2021)."}, {"Citation": "Aarogyam UK A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19, Available from: https://clinicaltrials.gov/ct2/show/NCT04621903 (Accessed on November 29, 2021b)."}, {"Citation": "Aarogyam UK Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research,Available from:https://clinicaltrials.gov/ct2/show/NCT04716647 (Accessed on November 29, 2021c)."}, {"Citation": "Kulkarni S.A., Nagarajan S.K., Ramesh V., Palaniyandi V., Selvam S.P., Madhavan T. Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 spike protein. J Mol Struct. 2020;1221 https://doi:10.1016/j.molstruc.2020.128823.", "ArticleIdList": ["PMC7334662", "32834111"]}, {"Citation": "Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis. 1997;18(15):2714\u20132723. https://doi:10.1002/elps.1150181505.", "ArticleIdList": ["9504803"]}, {"Citation": "Dong S., Sun J., Mao Z., Wang L., Lu Y.L., Li J. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV) J Med Virol. 2020;92(9):1542\u20131548. doi: 10.1002/jmv.25768.", "ArticleIdList": ["10.1002/jmv.25768", "PMC7228330", "32181901"]}, {"Citation": "Basu A., Sarkar A., Maulik U. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci Rep. 2020;10(1):17699. https://doi:10.1038/s41598-020-74715-4.", "ArticleIdList": ["PMC7573581", "33077836"]}, {"Citation": "Mohanraj K., Karthikeyan B.S., Vivek-Ananth R.P., et al. IMPPAT: a curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics. Sci Rep. 2018;8(1):4329. https://doi:10.1038/s41598-018-22631-z.", "ArticleIdList": ["PMC5847565", "29531263"]}, {"Citation": "Trott O., Olson A.J. AutoDockVina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u2013461. https://doi:10.1002/jcc.21334.", "ArticleIdList": ["PMC3041641", "19499576"]}, {"Citation": "Dallakyan S., Olson A.J. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243\u2013250. https://doi:10.1007/978-1-4939-2269-7_19.", "ArticleIdList": ["25618350"]}, {"Citation": "Islam M.R., Hoque M.N., Rahman M.S., et al. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Sci Rep. 2020;10(1):14004. https://doi:10.1038/s41598-020-70812-6.", "ArticleIdList": ["PMC7438523", "32814791"]}, {"Citation": "Mukhtar M., Arshad M., Ahmad M., et al. Antiviral potentials of medicinal plants. Virus Res. 2008;131(2):111\u2013120. https://doi:10.1016/j.virusres.2007.09.008.", "ArticleIdList": ["PMC7114233", "17981353"]}, {"Citation": "Woo Jackson C.S., Lau J.S.H., et al. Vol 62. Academic press; London: 2012. Herbal medicine: toxicity and recent trends in assessing their potential toxic effects; pp. 365\u2013384. (Advances in Botanical Research)."}, {"Citation": "MuthumanickamS Kamaladevi A., Boomi P., et al. Indian ethnomedicinal phytochemicals as promising inhibitors of RNA-binding domain of SARS-CoV-2 nucleocapsid phosphoprotein: an in silico study. Front Mol Biosci. 2021;8 https://doi:10.3389/fmolb.2021.637329.", "ArticleIdList": ["PMC8283196", "34277698"]}, {"Citation": "Vardhan S., Sahoo S.K. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19. Comput Biol Med. 2020;124 https://doi:10.1016/j.compbiomed.2020.103936.", "ArticleIdList": ["PMC7386496", "32738628"]}, {"Citation": "Kousar K., Majeed A., Yasmin F., et al. Phytochemicals from selective plants have promising potential against SARS-CoV-2: investigation and corroboration through molecular docking, md simulations, and quantum computations. Biomed Res Int. 2020;2020:6237160. https://doi:10.1155/2020/6237160.", "ArticleIdList": ["PMC7568149", "33102585"]}, {"Citation": "Warrier R.R., Priya S.M., Kalaiselvi R. Gmelina arborea- an indigenous timber species of India with high medicinal value: a review on its pharmacology, pharmacognosy and phytochemistry. J Ethnopharmacol. 2021;267 https://doi:10.1016/j.jep.2020.113593.", "ArticleIdList": ["33217516"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "12"}, {"Year": "2022", "Month": "4", "Day": "24"}, {"Year": "2022", "Month": "5", "Day": "4"}, {"Year": "2023", "Month": "10", "Day": "23", "Hour": "12", "Minute": "41"}, {"Year": "2022", "Month": "5", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "26", "Hour": "18", "Minute": "22"}, {"Year": "2022", "Month": "5", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35617830", "PMC9101941", "10.1016/j.jiph.2022.05.002", "S1876-0341(22)00122-8"]}}], "PubmedBookArticle": []}